-
Clinical Effectiveness and Safety of Reference and Biosimilar G-CSF As Primary Prophylaxis in DLBCL
Mar 10, 2025, 14:00 PM -
Real World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics
Mar 10, 2025, 14:00 PM -
Value of Liquid Biopsy for Genomic Profiling in Non-Small Cell Lung Cancer in France: A Pharmacoeconomic Model
Mar 10, 2025, 14:00 PM -
Access and Quality of Usual Source of Care and Racial/Ethnic Disparities in US Adults with Multiple Chronic Conditions
Mar 10, 2025, 14:00 PM -
Factors Affecting Per Capita Costs in Subdistrict Health Promotion Hospitals (SHPH) After Transfer to Provincial Administrative Organizations (PAO): A Study of Allocation Models in Thailand
Mar 10, 2025, 14:00 PM -
Use of Patient Support Program Data for Real-World Evidence Generation: Opportunities and Pitfalls Illustrated in a Case Study Assessing Trastuzumab Deruxtecan Among Patients With Breast Cancer
Mar 10, 2025, 14:00 PM -
Clinical and Economic Burden of Non-Obstructive Hypertrophic Cardiomyopathy: A Literature Review
Mar 10, 2025, 14:00 PM -
Patient, Caregiver, and Physician Perspectives on the Burden of Disease Chronic Refractory Gout and Its Treatment: Concept Elicitation
Mar 10, 2025, 14:00 PM -
Predicted vs. Actual Drug Spending for Interferon-Free Direct-Acting Antiviral Therapies in Hepatitis C: A Case Study on Drug Spending Forecasts
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Detection, Treatment, and Prevention Interventions for Perinatal Mood and Anxiety Disorders: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Performance of Unanchored Population-Adjusted Indirect Comparison Methods in Rare Disease Settings: A Simulation Study
Mar 10, 2025, 14:00 PM -
Evolution of Technology Diffusion within Brazilian Universal Healthcare System (Sistema Único de Saúde - SUS) 2+ Years After Listing of Antiangiogenics Treatment for Age-Related Macular Edema (AMD)
Mar 10, 2025, 14:00 PM -
Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Hospitalization Due to Heart Failure (HF) in Colombia
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Technological Innovation for Chronic Wounds: Pharmacoeconomic Model Based on LOGIT and MAIC Tools
Mar 10, 2025, 14:00 PM -
Healthcare Costs Associated With Adverse Events During Treatment Episodes for Pediatric Attention-Deficit/Hyperactivity Disorder
Mar 10, 2025, 14:00 PM -
Healthcare Resource Use in Commercially- and Medicaid-Insured Infants, Toddlers, and Children Diagnosed With Invasive Meningococcal Disease in the United States
Mar 10, 2025, 14:00 PM -
Transforming Regulatory Intelligence With AI Driven Methodologies in HEOR
Mar 10, 2025, 14:00 PM -
Identifying Treatment Patterns for Essential Thrombocythemia Using Real-world Data
Mar 10, 2025, 14:00 PM -
A Return On Investment Evaluation Of An Antibiotic Audit And Feedback Program Among Family Physicians
Mar 10, 2025, 14:00 PM -
Early Germline BRCA Testing in Breast Cancer: A Review of Value Frameworks and Cost-Effectiveness Analyses
Mar 10, 2025, 14:00 PM
